Consensus Virios Therapeutics, Inc.

Equities

VIRI

US92829J1043

Real-time Estimate Cboe BZX Other stock markets 03:15:59 2024-05-16 pm EDT			5-day change	1st Jan Change
0.385 ^USD	-5.29%		+5.96%	-31.34%

May. 09	Transcript : Virios Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024
May. 09	Virios Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Evolution of the average Target Price on Virios Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

7e15f7f3596dfe5f7938c3a7a7.GfCmAFNS5Ht9vfchHNz4zU1YHfvoE5R_0A6avEWkMhQ.UMfpUH5g1zIr8JZSUY-UnSssJLqQYMYzikbbyRfHXVc0o_ZTayegODncww~31218b29e6498b7e9e701149f703630c

Analyst Recommendations on Virios Therapeutics, Inc.

US Futures Lower as Investors Gird for Another Fed Rate Increase	22-09-20	MT
HC Wainwright Downgrades Virios Therapeutics to Neutral From Buy	22-09-20	MT
HC Wainwright Starts Virios Therapeutics at Buy With $12 Price Target	21-12-15	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

0.4065 USD

Average target price

2.2 USD

Spread / Average Target

+441.21%

High Price Target

4 USD

Spread / Highest target

+884.01%

Low Price Target

0.4 USD

Spread / Lowest Target

-1.60%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Virios Therapeutics, Inc.

HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar